By Professor David Thomas

Journal articles

Dudley AC; Thomas D; Best J; Jenkins A, 2005, 'A VEGF/JAK2/STAT5 axis may partially mediate endothelial cell tolerance to hypoxia', Biochemical Journal, 390, pp. 427 - 436, http://dx.doi.org/10.1042/BJ20050351

Thomas DM; Kuhn DM, 2005, 'MK-801 and dextromethorphan block microglial activation and protect against methamphetamine-induced neurotoxicity.', Brain Res, 1050, pp. 190 - 198, http://dx.doi.org/10.1016/j.brainres.2005.05.049

Thomas DM; Kuhn DM, 2005, 'Cyclooxygenase-2 is an obligatory factor in methamphetamine-induced neurotoxicity', JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 313, pp. 870 - 876, http://dx.doi.org/10.1124/jpet.104.080242

Morgan T; Atkins GJ; Trivett MK; Johnson SA; Kansara M; Schlicht SL; Slavin JL; Simmons P; Dickinson I; Powell G; Choong PFM; Holloway AJ; Thomas DM, 2005, 'Molecular profiling of giant cell tumor of bone and the osteoclastic localization of ligand for receptor activator of nuclear factor κB', American Journal of Pathology, 167, pp. 117 - 128, http://dx.doi.org/10.1016/S0002-9440(10)62959-8

Thomas DM; Kuhn DM, 2005, 'Attenuated microglial activation mediates tolerance to the neurotoxic effects of methamphetamine.', J Neurochem, 92, pp. 790 - 797, http://dx.doi.org/10.1111/j.1471-4159.2004.02906.x

Shannon J; Ray R; Wu C; Nelson Z; Gao DL; Li W; Hu W; Lampe J; Horner N; Satia J; Patterson R; Fitzgibbons D; Porter P; Thomas D, 2005, 'Food and botanical groupings and risk of breast cancer: a case-control study in Shanghai, China.', Cancer Epidemiol Biomarkers Prev, 14, pp. 81 - 90, https://www.ncbi.nlm.nih.gov/pubmed/15668480

Thomas DM; Johnson SA; Sims NA; Trivett MK; Slavin JL; Rubin BP; Waring P; McArthur GA; Walkley CR; Holloway AJ; Diyagama D; Grim JE; Clurman BE; Bowtell DDL; Lee JS; Gutierrez GM; Piscopo DM; Carty SA; Hinds PW, 2004, 'Terminal osteoblast differentiation, mediated by runx2 and p27 KIP1, is disrupted in osteosarcoma', Journal of Cell Biology, 167, pp. 925 - 934, http://dx.doi.org/10.1083/jcb.200409187

Thomas DM; Dowgiert J; Geddes TJ; Francescutti-Verbeem D; Liu X; Kuhn DM, 2004, 'Microglial activation is a pharmacologically specific marker for the neurotoxic amphetamines.', Neurosci Lett, 367, pp. 349 - 354, http://dx.doi.org/10.1016/j.neulet.2004.06.065

Thomas DM; Fleming NI; Holloway AJ; Bowtell DDL, 2004, 'Molecular medicine: A clinician's primer on microarrays', Internal Medicine Journal, 34, pp. 565 - 569, http://dx.doi.org/10.1111/j.1445-5994.2004.00680.x

Dudley AC; Thomas D; Best J; Jenkins A, 2004, 'The STATs in cell stress-type responses', Cell Communication and Signaling, 2, http://dx.doi.org/10.1186/1478-811X-2-8

Thomas DM; Francescutti-Verbeem DM; Liu X; Kuhn DM, 2004, 'Identification of differentially regulated transcripts in mouse striatum following methamphetamine treatment--an oligonucleotide microarray approach.', J Neurochem, 88, pp. 380 - 393, http://dx.doi.org/10.1046/j.1471-4159.2003.02182.x

Thomas DM; Walker PD; Benjamins JA; Geddes TJ; Kuhn DM, 2004, 'Methamphetamine neurotoxicity in dopamine nerve endings of the striatum is associated with microglial activation.', J Pharmacol Exp Ther, 311, pp. 1 - 7, http://dx.doi.org/10.1124/jpet.104.070961

Dudley A; Gilbert RE; Thomas D; Cox A; Price JT; Best J; Jenkins A, 2003, 'STI-571 inhibits in vitro angiogenesis', Biochemical and Biophysical Research Communications, 310, pp. 135 - 142, http://dx.doi.org/10.1016/j.bbrc.2003.08.129

Chin SL; Johnson SA; Quinn J; Mirosavljevic D; Price JT; Dudley AC; Thomas DM, 2003, 'A role for αV integrin subunit in TGF-β-stimulated osteoclastogenesis', Biochemical and Biophysical Research Communications, 307, pp. 1051 - 1058, http://dx.doi.org/10.1016/S0006-291X(03)01294-4

Thomas DM; Yang HS; Alexander K; Hinds PW, 2003, 'Role of the retinoblastoma protein in differentiation and senescence', Cancer Biology and Therapy, 2, pp. 124 - 130, http://dx.doi.org/10.4161/cbt.2.2.235

Dudley A; McKinstry W; Thomas D; Best J; Jenkins A, 2003, 'Removal of endotoxin by reverse phase HPLC abolishes anti-endothelial cell activity of bacterially expressed plasminogen kringle 5', Biotechniques, 35, pp. 724 - 732, http://dx.doi.org/10.2144/03354st02

Cook N; Thomas DM, 2002, 'Retrospective survey of unselected hospital patients with and without cancer comparing outcomes following venous thromboembolism', Internal Medicine Journal, 32, pp. 437 - 444, http://dx.doi.org/10.1046/j.1445-5994.2002.00249.x

Rosenthal MA; Thomas D; Davis I; Toner G; Noordin N; Zalcberg J, 2001, 'Pilot study of oral eniluracil/5-FU in the palliation of hormone-refractory prostate cancer', Prostate Journal, 3, pp. 30 - 35, http://dx.doi.org/10.1046/j.1525-1411.2001.003001030.x

Thomas DM; Carty SA; Piscopo DM; Lee JS; Wang WF; Forrester WC; Hinds PW, 2001, 'The retinoblastoma protein acts as a transcriptional coactivator required for osteogenic differentiation', Molecular Cell, 8, pp. 303 - 316, http://dx.doi.org/10.1016/S1097-2765(01)00327-6

Li HQ; Thomas DB; Berry G; MacLennan R; Shearman R; Jelihovsky T; Booth JC; Molina R; Martinez L; Salas O; Dabancens A; Cuadros A; Aristizabal N; Berry G; Modan B; Ron E; Alfandary E; Mati JG; Kenya P; Kungu A; Gatei D; Cuevas HR; Salazar SB; Palet A; Ontiveros P; Apelo RA; De la Cruz JR; Baens J; Canlas BD; Silpisornkosol S; Pardthaisong T; Charoeniam V; Theetranont C; Boosiri B; Chutivongse S; Virutamasen P; Wongsrichanalai C; Sindhavananda S; Koetsawang S; Rachawat D; Koetsawang A; Riotton G; Christopherson WM; Melnick JL; Adam E; Meirik O; Farley TMM; Holck S, 2000, 'Tubal ligation and risk of cervical cancer', Contraception, 61, pp. 323 - 328, http://dx.doi.org/10.1016/S0010-7824(00)00111-6

Puche RC; Thomas DM; Udagawa N; Hards DK; Quinn JMW; Moseley JM; Findlay DM; Best JD, 1999, 'Letters to the editor (multiple letters).', Bone, 25, pp. 251, http://dx.doi.org/10.1016/s8756-3282(99)00159-3

Ebeling PR; Thomas DM; Erbas B; Hopper JL; Szer J; Grigg AP, 1999, 'Mechanisms of bone loss following allogeneic and autologous hemopoietic stem cell transplantation', Journal of Bone and Mineral Research, 14, pp. 342 - 350, http://dx.doi.org/10.1359/jbmr.1999.14.3.342

Thomas DM; Ferguson GD; Herschman HR; Elferink LA, 1999, 'Functional and biochemical analysis of the C2 domains of synaptotagmin IV.', Mol Biol Cell, 10, pp. 2285 - 2295, http://dx.doi.org/10.1091/mbc.10.7.2285

Ferguson GD; Thomas DM; Elferink LA; Herschman HR, 1999, 'Synthesis degradation, and subcellular localization of synaptotagmin IV, a neuronal immediate early gene product.', J Neurochem, 72, pp. 1821 - 1831, http://dx.doi.org/10.1046/j.1471-4159.1999.0721821.x

Kuhn DM; Arthur RE; Thomas DM; Elferink LA, 1999, 'Tyrosine hydroxylase is inactivated by catechol-quinones and converted to a redox-cycling quinoprotein: possible relevance to Parkinson's disease.', J Neurochem, 73, pp. 1309 - 1317, http://dx.doi.org/10.1046/j.1471-4159.1999.0731309.x

Thomas DM; Mitchell PLR; Berlangieri SU; Tochon-Danguy H; Knight S; Clarke CP; Scott AM, 1998, 'Correction: Positron emission tomography in assessing response to neoadjuvant chemotherapy for non-small-cell lung cancer (Medical Journal of Australia (1998) 169 (227))', Medical Journal of Australia, 169, pp. 344

Thomas DM; Mitchell PLR; Berlangieri SU; Tochon-Danguy H; Knight S; Clarke CP; Scott AM, 1998, 'Positron emission tomography in assessing response to neoadjuvant chemotherapy for non-small-cell lung cancer (vol 169, pg 227, 1998)', MEDICAL JOURNAL OF AUSTRALIA, 169, pp. 344 - 344, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000076023200028&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Thomas DM; Udagawa N; Hards DK; Quinn JMW; Moseley JM; Findlay DM; Best JD, 1998, 'Insulin receptor expression in primary and cultured osteoclast-like cells', Bone, 23, pp. 181 - 186, http://dx.doi.org/10.1016/S8756-3282(98)00095-7

Thomas DM; Elferink LA, 1998, 'Functional analysis of the C2A domain of synaptotagmin 1: implications for calcium-regulated secretion.', J Neurosci, 18, pp. 3511 - 3520, http://dx.doi.org/10.1523/JNEUROSCI.18-10-03511.1998

Thomas DM; Zalcberg JR, 1998, '5-Fluorouracil: A pharmacological paradigm in the use of cytotoxics', Clinical and Experimental Pharmacology and Physiology, 25, pp. 887 - 895, http://dx.doi.org/10.1111/j.1440-1681.1998.tb02339.x

Thomas DM; Mitchell PLR; Berlangieri SU; Tochon-Danguy H; Knight S; Clarke CP; Scott AM, 1998, 'Positron emission tomography in assessing response to neoadjuvant chemotherapy for non-small-cell lung cancer [1]', Medical Journal of Australia, 169, pp. 227, http://dx.doi.org/10.5694/j.1326-5377.1998.tb140229.x

Thomas DM; Seymour JF; Szer J; Grigg AP; Basser RL; Green MD; Fox RM; Thomas DM, 1998, 'Progress in management of acute myeloid leukaemia (AML) in Australia since 1980: A single institution retrospective study', Australian and New Zealand Journal of Medicine, 28, pp. 190 - 196, http://dx.doi.org/10.1111/j.1445-5994.1998.tb02968.x

Rosenblatt K; Thomas D, 1997, 'Association between tubal ligation and endometrial cancer.', Int J Cancer, 71, pp. 129 - 130, http://dx.doi.org/10.1002/(sici)1097-0215(19970328)71:1<129::aid-ijc22>3.0.co;2-c

Thomas DM; Ng KW; Best JD, 1997, 'Insulin and bone: A clinical and scientific review', Endocrinology and Metabolism Supplement, 4, pp. 5 - 17

Thomas DM; Seymour JF; Griffiths JD; Szer J; Grigg AP, 1997, 'Prolonged disease-free survival with specific re-induction therapy in acute myeloid leukaemia relapsing following bone marrow transplantation', Australian and New Zealand Journal of Medicine, 27, pp. 712 - 713, http://dx.doi.org/10.1111/j.1445-5994.1997.tb01009.x

Rosenblatt KA; Thomas DB; Berry G; MacLennan R; Shearman R; Jelihovsky T; Booth JC; Molina R; Martinez L; Salas O; Dabancens A; Zhiheng C; Yun T; Wei HY; Modan B; Ron E; Alfandary E; Rodriguez Cuevas H; Benavides Salazar S; Palet A; Ontiveros P; Apelo RA; De La Cruz JR; Baens J; Javier B; Silpisornkosol S; Pardthaisong T; Martin N; Theetranont C; Boosiri B; Chutivongse S; Virutamasen P; Wongsrichanalai C; Jimakorn P; Koetsawang S; Rachawat D; Chantarakul N; Langley FA; Noonan EA; Hoick S; Farley T; Meirik O, 1996, 'Intrauterine devices and endometrial cancer', Contraception, 54, pp. 329 - 332, http://dx.doi.org/10.1016/S0010-7824(96)00199-0

Thomas DM; Maher F; Rogers SD; Best JD, 1996, 'Expression and regulation by insulin of Glut 3 in UMR 106-01, a clonal rat osteosarcoma cell line', Biochemical and Biophysical Research Communications, 218, pp. 789 - 793, http://dx.doi.org/10.1006/bbrc.1996.0140

Thomas DM; Rogers SD; Ng KW; Best JD, 1996, 'Dexamethasone modulates insulin receptor expression and subcellular distribution of the glucose transporter GLUT 1 in UMR 106-01, a clonal osteogenic sarcoma cell line', Journal of Molecular Endocrinology, 17, pp. 7 - 17, http://dx.doi.org/10.1677/jme.0.0170007

Thomas DM; Hards DK; Rogers SD; Ng KW; Best JD, 1996, 'Insulin receptor expression in bone', Journal of Bone and Mineral Research, 11, pp. 1312 - 1320, http://dx.doi.org/10.1002/jbmr.5650110916

Thomas DM; Rogers SD; Sleeman MW; Pasquini GM; Bringhurst FR; Ng KW; Zajac JD; Best JD, 1995, 'Modulation of glucose transport by parathyroid hormone and insulin in UMR 106-01, a clonal rat osteogenic sarcoma cell line', Journal of Molecular Endocrinology, 14, pp. 263 - 275, http://dx.doi.org/10.1677/jme.0.0140263

Prentice RL; Thomas D, 1993, 'Methodologic research needs in environmental epidemiology: data analysis.', Environ Health Perspect, 101 Suppl 4, pp. 39 - 48, http://dx.doi.org/10.1289/ehp.93101s439

Lazovich D, 1992, 'Breast-Conserving Surgery and Radiation Therapy: Are They Underused?-Reply', JAMA: The Journal of the American Medical Association, 268, pp. 869 - 869, http://dx.doi.org/10.1001/jama.1992.03490070047024

Silpisornkosol S; Pardthaisong T; Sahapong V; Theetranont C; Boosiri B; Chutivongse S; Virutamasen P; Wongsrchanalai C; Sindhvananda S; Koetsawang S; Rachawat D; Koetsawang A; Langley FA; Thomas Study Coordinator DB; Ray RM; Noonan EA; Stanford JL; Rosenblatt KA; Holck S; Farley TMM; Thomas DB, 1991, 'Depot‐medroxyprogesterone acetate (dmpa) and risk of edometrial cancer', International Journal of Cancer, 49, pp. 186 - 190, http://dx.doi.org/10.1002/ijc.2910490207

Witherspoon RP; Fisher LD; Schoch G; Martin P; Sullivan KM; Sanders J; Deeg HJ; Doney K; Thomas D; Storb R, 1989, 'Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia.', N Engl J Med, 321, pp. 784 - 789, http://dx.doi.org/10.1056/NEJM198909213211203

Severson RK; Stevens RG; Davis S; Thomas D; Heuser L; Sever LE, 1989, 'THE AUTHORS REPLY', American Journal of Epidemiology, 130, pp. 425 - 427, http://dx.doi.org/10.1093/oxfordjournals.aje.a115352

Back to profile page